Alkon Daniel L. 4
4 · Synaptogenix, Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Alkon Daniel L.
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock, par value $0.0001 per share
2022-12-16$1.17/sh−19,688$23,072→ 35,546 total
Footnotes (1)
- [F1]Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.